Coccidioidomycosis (Valley Fever)
Coccidioidomycosis (Valley Fever) is a benign fungal disease affecting cattle and dogs. It creates a major public health problems in human.
Coccidioidomycosis (Valley Fever) is a non contagious infection.
Etiology
- Coccidioides immitis cause Coccidioidomycosis (Valley Fever).
- C. immitis is a dimorphic, saprophytic organism develops as a mycelium in the soil and produces a spherules within the host.
- Arthroconidia (arthrospores) produced by the hyphae are the infectious units of the organism.
- The spores are known as arthroconidia (Barrel shaped).
- C. immitis colonies grow rapidly. It produce white, cottony colonies and in old culture it turn to tan to brown color.
- It is dormant during long dry period and develops as a mold with long filaments that break off into airborne spores following rainfall.
Epidemiology
Prevalence of infection
- It is enzootic in South West US and up to 20% of cattle reared under feed lot condition.
- It is a fungal disease and is sporadic in distribution.
- Coccidioides spp. is endemic in hot and semi-arid zones.
- The organism is detected in humans or animals present in endemic areas.
Predisposing factors
- Coccidioides spp. grows in the soil as mycelia with lateral growing “barrel” shaped arthroconidia.
- Coccidioides lies dormant in the mycelial phase during the times of draught, but heavy rain causes germination of the arthroconidia and production of more mycelia.
- Infection occurs most often during dry weather disperse the conidia more easily following periods of heavy rain and wind.
- Soil also promote exposure.
Transmission
- The disease spread by means of inhalation of spores which are saprophytic in nature.
- Infection may also occur through cutaneous abrasions.
- The disease is not transmitted from person to person.
Host affected
- Cattle, deer, dogs, elk, fish, mules, apes, kangaroos, wallabies, tigers, bears, badgers, otters and marine mammals are affected.
- The disease also affects lesser extent the species such as pigs, sheep and horses.
- Pulmonary coccidioidomycosis recorded in adult foal.
- Human beings are affected.
Pathogenesis
- Following inhalation of the arthroconidia, few conidia can produce infection.
- Arthroconidia are distributed through the alveoli phagocytosed and develops to spherules, which then enlarge and undergo endosporulation.
- The spherules rupture and release endospores into surrounding tissues, and spread locally or disseminate hematogenously to extra pulmonary sites.
- The endospores develop into spherules and continue the cycle until host develop resistance.
- Reactivation of latent infection is thought to occur in immunosuppressed patients.
- T lymphocytes recognizing coccidioides antigens in the first four to six weeks of infection and activate macrophages to halt progression of infection.
- In humans, those with impaired cell mediated immunity suffer from severe form of progressive coccidioidomycosis.
- If conidia inhaled, they produce spherules, thus propagating the infection.
- The hematogenous spread of the pathogen in the host’s bloodstream results in infection of skin, bones, joints, lymph nodes, adrenal glands and central nervous system.
- Once the arthroconidia are inhaled, the fungus develops into 30-60 micron diameter spherules that are filled with 3-5 micron diameter endospores.
- The large spherules then release the endospores that continue the infection.
Clinical Signs
- Weight loss, severe emaciation, fluctuation of body temperature, persistent cough, muscle pain, superficial abscesses with frequent recurrence.
- Muscle pain and development of superficial abscess in pectoral area is most common.
- Increased lung sounds, wheezing, dullness are audible over the vertical chest area.
- Other signs includes edema of legs, anaemia, intermittent colic due to internal abscesses and peritoneal adhesions.
- Death due to rupture of liver occurs.
Necropsy Findings
- Cattle and pigs develops granulomatous lesion which contains a creamy coloured pus, calcified materials in bronchial, mediastinal, rarely in mesentric, pharyngeal, submaxillary and supramammary lymphnodes.
- Lungs of neonatal foal contains diffusely infiltrated miliary pattern of multiple, coalescing, pale tan to red irregular shaped slightly raised firm foci 0.1-0.5 cm in diameter.
Diagnosis
- Based on clinical signs and necropsy findings.
- Isolation and identification of organism.
- An extract of fungal antigen, coccidioidin used in an intradermal sensitivity test.
- CFT and Immuno diffusion test in humans.
Differential Diagnosis
- TB
- Caseous lymphadenitis
Treatment
- Oral antifungal agents such as ketoconazole, itraconazole, and fluconazole are given.
- The role of newer agents, such as voriconazole, posaconazole and caspofungin are still being tried.
- It is often a self-limiting chronic respiratory or multisystemic disease and it requires a long term antifungal therapy.
- For disseminated infection, treatment of at least 6-12 months is required.
- Ketoconazole (10-30 mg/kg/day) or itraconazole (10 mg/kg/day) is commonly used to treat dogs.
- Amphotericin-B may be used in animals not responding to azole antifungals.
- Fluconazole also be effective. The use of long term fluconazole (2-3 mg/kg/day) resulted in a 55% success rate in monkeys with coccidioidomycosis.
- Coccidioidomycotic osteomyelitis in a horse has been successfully treated with itraconazole 2.6 mg/kg body weight twice a day for 6 months.
Prevention
- Dust control is a major factor in prevention of human coccidioidomycosis.
- No vaccine is available.
- Infection occurs by inhalation of soil borne spores.
- Control of dust in feed lots may help to prevent the spread.
Control
- Eradication of spores from soil is not feasible.
- Halogens (such as iodine, and chlorine in the form of hypochlorite [bleach]), phenolics and quaternary ammonium compounds are proven effective against Coccidioides spp.
- Arthroconidia are resistant to dry heat, but they can be inactivated by moist heat (121°C for a minimum of 15 minutes).